54
A interface vítreo-retiniana
AVM, TVM e BM
25 Perguntas e respostas
Relativamente ao tratamento, e dada a ele-
vada taxa de resolução espontânea, a maio-
ria dos autores advoga uma atitude con-
servadora, estando a cirurgia normalmente
reservada para buracos maculares de es-
pessura completa. Isto é sobretudo válido
em doentes com poucas queixas visuais e/
ou em que o olho adelfo é normal
5,8
. Mais
recentemente e com o advento da vitreólise
enzimática, menos invasiva, tornou-se ra-
zoável o tratamento mais precoce de doen-
tes sintomáticos com
impending macular
hole
ou TVM em que as queixas visuais se-
jam relevantes
7,9
.
REFERÊNCIAS
1.
Gass JD. Idiopathic senile macular hole. Its
early stages and pathogenesis. Arch Ophthal-
mol 1988;106(5):629-39.
2.
Gass JD. Reappraisal of biomicroscopic clas-
sification of stages of development of a macu-
lar hole. Am J Ophthalmol 1995;119(6):752-9.
3.
Johnson RN, Gass JD. Idiopathic macular
holes. Observations, stages of formation, and
implications for surgical intervention. Ophthal-
mology 1988;95(7):917-24.
4.
Gaudric A, Haouchine B, Massin P, Paques M,
Blain P, Erginay A. Macular hole formation: new
data provided by optical coherence tomogra-
phy. Arch Ophthalmol 1999;117(6):744-51.
5.
Agarwall A. Gass’ Atlas of Macular Diseases.
5th ed. Nashville, TN: Saunders Elsevier; 2012.
6.
Takahashi A, Nagaoka T, Yoshida A. Stage 1-A
macular hole: a prospective spectral-domain
optical coherence tomography study. Retina
2011;31(1):127-47.
7.
Duker JS, Kaiser PK, Binder S, de Smet
MD, Gaudric A, Reichel E et al. The Interna-
tional Vitreomacular Traction Study Group
classification of vitreomacular adhesion,
traction, and macular hole. Ophthalmology
2013;120(12):2611-9.
8.
de Bustros S. Vitrectomy for prevention of
macular holes. Results of a randomized mul-
ticenter clinical trial. Vitrectomy for Prevention
of Macular Hole Study Group. Ophthalmology
1994;101(6):1055-9.
9.
Stalmans P, Benz MS, Gandorfer A, Kampik
A, Girach A, Pakola S et al. MIVI-TRUST Study
Group. Enzymatic vitreolysis with ocriplasmin
for vitreomacular traction and macular holes.
N Engl J Med 2012;367(7):606-15.




